IL10 Receptor Binding Molecules and Methods of Use - EP4192880A2

The European Patent Office published patent application EP4192880A2 for IL10 receptor binding molecules and methods of use, filed by Synthekine, Inc. The application covers peptide-based compounds (C07K classification) that bind IL10 receptors and their therapeutic applications. Inventors include KASTELEIN, ROKKAM, LUPARDUS, VIVONA, and RAMADASS. The A2 publication indicates the application has been formally published with claims but without the international search report.

For companies developing biologics or peptide therapeutics targeting IL10 or related immunological pathways, this patent represents potential freedom-to-operate considerations. Competitors pursuing similar receptor binding molecules may need to evaluate design-around options or seek licensing. The broad designation of all EPC contracting states means the patent could eventually obtain protection across the entire European market if granted after examination.